Jeffrey Leiden Unloaded $3,605,547 Worth of Vertex Pharmaceuticals (VRTX) Shares; Profile of 9 Analysts Covering Semtech (SMTC)

On 14/02/2018, a big insider trading trade was made. Jeffrey Leiden, the CEO & President and an insider of Vertex Pharmaceuticals Inc Ma sold precisely 23,905 shares of Vertex Pharmaceuticals Inc Ma, worth roughly $3,605,547 U.S Dollars, at $150.8 for share at the time of the trade. This is not his first insider trade, in the last 30 days, he unloaded another 99,563 shares worth $15,630,614 USD. Having been a very big insider stocks unloading at Vertex Pharmaceuticals Inc Ma, the probability that it remains a secret for long was obviously very low. Jeffrey Leiden currently holds 191,098 shares which are around 0.08% of the Massachusetts-Company’s market cap. This deal was performed on 14/02/2018. A form that was filed with the (SEC) and free at your disposal here, gives full details of the deal.

Among 12 analysts covering Semtech (NASDAQ:SMTC), 9 have Buy rating, 0 Sell and 3 Hold. Therefore 75% are positive. Semtech had 33 analyst reports since August 3, 2015 according to SRatingsIntel. The stock of Semtech Corporation (NASDAQ:SMTC) earned “Buy” rating by B. Riley & Co on Monday, November 16. The rating was maintained by Needham with “Buy” on Thursday, January 18. The stock has “Hold” rating by RBC Capital Markets on Wednesday, May 31. Oppenheimer maintained Semtech Corporation (NASDAQ:SMTC) rating on Monday, May 29. Oppenheimer has “Buy” rating and $4200 target. Oppenheimer maintained the stock with “Buy” rating in Wednesday, December 6 report. The firm has “Hold” rating by RBC Capital Markets given on Monday, July 3. Drexel Hamilton maintained Semtech Corporation (NASDAQ:SMTC) rating on Thursday, November 30. Drexel Hamilton has “Buy” rating and $45.0 target. The stock of Semtech Corporation (NASDAQ:SMTC) earned “Sell” rating by B. Riley & Co on Friday, August 14. The company was maintained on Thursday, June 29 by Oppenheimer. The rating was downgraded by M Partners to “Neutral” on Friday, September 25. See Semtech Corporation (NASDAQ:SMTC) latest ratings:

18/01/2018 Broker: Needham Rating: Buy New Target: $42.0 Maintain
05/01/2018 Broker: Roth Capital Rating: Buy New Target: $39 Initiates Coverage On
19/12/2017 Broker: PiperJaffray Rating: Neutral New Target: $35 Initiates Coverage On
11/12/2017 Broker: Needham Rating: Buy New Target: $42.0 Initiate
06/12/2017 Broker: Oppenheimer Rating: Buy Maintain
30/11/2017 Broker: RBC Capital Markets Rating: Hold New Target: $34.0 Maintain
30/11/2017 Broker: Drexel Hamilton Rating: Buy New Target: $45.0 Maintain
27/11/2017 Broker: FBR Capital Rating: Buy New Target: $48.0
20/11/2017 Broker: BWS Financial Rating: Buy New Target: $49 Initiates Coverage On
02/10/2017 Broker: RBC Capital Markets Rating: Hold New Target: $39.0 Maintain

Since August 15, 2017, it had 0 buys, and 28 sales for $3.86 million activity. Another trade for 2,500 shares valued at $89,093 was sold by MAHESWARAN MOHAN. KIM JAMES JUNGSUP also sold $54,075 worth of Semtech Corporation (NASDAQ:SMTC) on Friday, January 5. 5,000 shares valued at $188,266 were sold by BURRA JAMES P on Thursday, October 5. Shares for $32,532 were sold by Costello Mark C. CHUKWU EMEKA sold 2,000 shares worth $76,000. Another trade for 1,100 shares valued at $44,310 was sold by Silberstein Asaf. 2,250 shares were sold by Ammann Charles B., worth $84,875.

Investors sentiment decreased to 1.02 in Q3 2017. Its down 0.05, from 1.07 in 2017Q2. It turned negative, as 16 investors sold Semtech Corporation shares while 74 reduced holdings. 30 funds opened positions while 62 raised stakes. 61.66 million shares or 0.19% less from 61.78 million shares in 2017Q2 were reported. Laurion Cap Limited Partnership stated it has 0% in Semtech Corporation (NASDAQ:SMTC). Aqr Mgmt Limited Liability Corp has 115,243 shares for 0.01% of their portfolio. 8,145 were accumulated by Aspen Inv. Pnc Financial Services Gp Inc has invested 0% in Semtech Corporation (NASDAQ:SMTC). Point72 Asia (Hong Kong) Ltd invested in 0.01% or 408 shares. Sheets Smith Wealth Mgmt stated it has 21,087 shares. Contravisory Investment Mngmt has invested 0% in Semtech Corporation (NASDAQ:SMTC). Ny State Common Retirement Fund owns 231,103 shares. New York State Teachers Retirement System has invested 0.01% in Semtech Corporation (NASDAQ:SMTC). Eam Invsts Ltd Com holds 46,504 shares. Moreover, Cornercap Counsel has 0.1% invested in Semtech Corporation (NASDAQ:SMTC) for 19,520 shares. Jennison Associates Ltd Liability Com accumulated 52,055 shares or 0% of the stock. Employees Retirement System Of Ohio reported 162,808 shares. Qs Investors Limited Com invested in 137,756 shares. Kennedy Cap Management Inc has invested 0.05% in Semtech Corporation (NASDAQ:SMTC).

Semtech Corporation designs, develops, makes, and markets analog and mixed-signal semiconductor products. The company has market cap of $2.18 billion. The firm provides signal integrity products, including a portfolio of optical communications, broadcast video, and backplane products used in various enterprise computing, industrial, communications, and high-end consumer applications; and a portfolio of integrated circuits for optical transceivers, backplane, and high-speed interface applications. It has a 48.17 P/E ratio. It also offers protection products, such as filter and termination devices that are integrated with the transient voltage suppressor devices, which protect electronic systems from voltage spikes; and wireless and sensing products comprising a portfolio of specialized radio frequency products used in various industrial, medical, and communications applications, as well as specialized sensing products used in industrial and consumer applications.

The stock increased 1.08% or $0.35 during the last trading session, reaching $32.85. About 777,392 shares traded or 25.60% up from the average. Semtech Corporation (NASDAQ:SMTC) has risen 72.29% since February 15, 2017 and is uptrending. It has outperformed by 55.59% the S&P500.

Since August 31, 2017, it had 0 buys, and 37 insider sales for $109.10 million activity. Shares for $8.70 million were sold by Chodakewitz Jeffrey. The insider MCGLYNN MARGARET G sold 20,000 shares worth $3.25M. ALTSHULER DAVID had sold 1,796 shares worth $287,360 on Monday, January 22. On Monday, February 5 the insider Sachdev Amit sold $736,800. LEIDEN JEFFREY M had sold 125,000 shares worth $17.67M. SMITH IAN F also sold $10.88 million worth of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Tuesday, October 31. 5,435 Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) shares with value of $891,487 were sold by Silva Paul M.

Among 30 analysts covering Vertex Pharmaceuticals (NASDAQ:VRTX), 26 have Buy rating, 0 Sell and 4 Hold. Therefore 87% are positive. Vertex Pharmaceuticals has $212.0 highest and $85.0 lowest target. $178.31’s average target is 13.39% above currents $157.26 stock price. Vertex Pharmaceuticals had 96 analyst reports since July 31, 2015 according to SRatingsIntel. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Overweight” rating by Morgan Stanley on Friday, October 2. The stock has “Buy” rating by JMP Securities on Tuesday, December 12. The rating was maintained by H.C. Wainwright with “Hold” on Thursday, October 26. The company was maintained on Wednesday, January 31 by RBC Capital Markets. On Tuesday, July 18 the stock rating was maintained by BMO Capital Markets with “Buy”. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Buy” rating by Maxim Group on Thursday, July 27. The rating was maintained by Leerink Swann on Tuesday, March 8 with “Outperform”. Cowen & Co maintained Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) on Monday, September 25 with “Buy” rating. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Outperform” rating by BMO Capital Markets on Wednesday, March 29. The stock of Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) earned “Buy” rating by Stifel Nicolaus on Tuesday, December 1.

Investors sentiment increased to 1.62 in 2017 Q3. Its up 0.11, from 1.51 in 2017Q2. It increased, as 32 investors sold Vertex Pharmaceuticals Incorporated shares while 151 reduced holdings. 79 funds opened positions while 217 raised stakes. 231.42 million shares or 0.04% more from 231.33 million shares in 2017Q2 were reported. Fiera Capital Corporation reported 2,104 shares stake. Pennsylvania, a Pennsylvania-based fund reported 1,445 shares. Moreover, Ameriprise has 0.39% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Bain Public Equity Ltd has invested 1.64% of its portfolio in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). British Columbia Invest Mngmt holds 202,372 shares or 0.24% of its portfolio. 16,800 are owned by Quantres Asset Ltd. Suntrust Banks Inc, a Georgia-based fund reported 26,937 shares. Ig Inv Mngmt Ltd has invested 0.01% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Cornerstone Mngmt Ltd Liability Corporation has 0.05% invested in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). 5,051 are owned by Advisor Ltd Company. Louisiana State Employees Retirement Sys holds 0.11% or 15,700 shares. Lord Abbett Limited Liability accumulated 0.3% or 678,358 shares. Botty Investors Limited Liability Com has invested 0.48% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX). Kentucky Retirement System holds 15,293 shares or 0.18% of its portfolio. Quantitative Systematic Strategies Lc has invested 0.1% in Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX).